Details for Patent: 8,318,788
✉ Email this page to a colleague
Which drugs does patent 8,318,788 protect, and when does it expire?
Patent 8,318,788 protects CONTRAVE and is included in one NDA.
This patent has thirty-nine patent family members in eighteen countries.
Summary for Patent: 8,318,788
| Title: | Layered pharmaceutical formulations |
| Abstract: | In one embodiment a layered pharmaceutical formulation includes two or more pharmaceutical layers and an intermediate layer disposed between at least two of the two or more pharmaceutical layers, the intermediate layer configured to dissolve in vivo to thereby leave the two or more pharmaceutical layers substantially intact. In one embodiment, an active pharmaceutical ingredient in at least one of the pharmaceutical layers is selected from bupropion, zonisamide, naltrexone, topiramate, phentermine, metformin, olanzapine and fluoxetine. |
| Inventor(s): | McKinney; Anthony (San Diego, CA), Tollefson; Gary (Indianapolis, IN), Weber; Eckard (San Diego, CA), Soltero; Rick (Holly Springs, NC) |
| Assignee: | Orexigen Therapeutics, Inc. (La Jolla, CA) |
| Application Number: | 13/330,395 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,318,788 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,318,788
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF NALTREXONE AND BUPROPION IN A LAYERED FORMULATION FOR CHRONIC WEIGHT MANAGEMENT FOR AFFECTING WEIGHT LOSS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,318,788
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 063959 | ⤷ Sign Up | |||
| Austria | E460925 | ⤷ Sign Up | |||
| Australia | 2007319471 | ⤷ Sign Up | |||
| Canada | 2668884 | ⤷ Sign Up | |||
| Chile | 2007003245 | ⤷ Sign Up | |||
| China | 101588795 | ⤷ Sign Up | |||
| Germany | 602007005402 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
